From the source
From the source
From the source
From the source
Alphabet Inc.’s Isomorphic Labs, which is working to design new drugs with artificial intelligence, has raised $5 billion in a funding round helmed by Silicon Valley titans just six months after announcing its last fundraising effort.
bloomberg.com